---
figid: PMC7142254__fcell-08-00233-g003
figlink: pmc/articles/PMC7142254/figure/F3/
number: F3
caption: Targeting USP7-MDM2/MDMX-p53 network for cancer therapy. Several small-molecule
  inhibitors have been developed to broadly inhibit the deubiquitinating activity
  of USP7 without direct binding (Strategy 1), via covalent binding (Strategy 2),
  or via non-covalent binding (Strategy 3), therefore inducing the degradation of
  MDM2 and MDMX and stabilizing and activating p53. These compounds have shown anticancer
  efficacy in vitro and in vivo. Directly inhibiting the bindings of USP7 to MDM2
  (Strategy 4) and MDMX (Strategy 5) may be examined to develop more safe and effective
  inhibitors for cancer therapy.
pmcid: PMC7142254
papertitle: 'Targeting USP7-Mediated Deubiquitination of MDM2/MDMX-p53 Pathway for
  Cancer Therapy: Are We There Yet?.'
reftext: Si-Min Qi, et al. Front Cell Dev Biol. 2020;8:233.
pmc_ranked_result_index: '59077'
pathway_score: 0.8113119
filename: fcell-08-00233-g003.jpg
figtitle: Targeting USP7-MDM2/MDMX-p53 network for cancer therapy
year: '2020'
organisms:
- Mus musculus
- herbal medicine
- Stylissa massa
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7142254__fcell-08-00233-g003.html
  '@type': Dataset
  description: Targeting USP7-MDM2/MDMX-p53 network for cancer therapy. Several small-molecule
    inhibitors have been developed to broadly inhibit the deubiquitinating activity
    of USP7 without direct binding (Strategy 1), via covalent binding (Strategy 2),
    or via non-covalent binding (Strategy 3), therefore inducing the degradation of
    MDM2 and MDMX and stabilizing and activating p53. These compounds have shown anticancer
    efficacy in vitro and in vivo. Directly inhibiting the bindings of USP7 to MDM2
    (Strategy 4) and MDMX (Strategy 5) may be examined to develop more safe and effective
    inhibitors for cancer therapy.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - USP7
  - GNE
  - MDM4
  - MDM2
  - TP53
  - Spongiacidin C
  - Thiazole
  - GNE-6776
  - XL188
  - CDDO-Me,
  - Berberine
  - DM
genes:
- word: USP7
  symbol: USP7
  source: hgnc_symbol
  hgnc_symbol: USP7
  entrez: '7874'
- word: USP7
  symbol: USP7
  source: hgnc_symbol
  hgnc_symbol: USP7
  entrez: '7874'
- word: USP7
  symbol: USP7
  source: hgnc_symbol
  hgnc_symbol: USP7
  entrez: '7874'
- word: GNE-
  symbol: GNE
  source: hgnc_symbol
  hgnc_symbol: GNE
  entrez: '10020'
- word: USP7-
  symbol: USP7
  source: hgnc_symbol
  hgnc_symbol: USP7
  entrez: '7874'
- word: MDMX
  symbol: MDMX
  source: hgnc_alias_symbol
  hgnc_symbol: MDM4
  entrez: '4194'
- word: USP7-
  symbol: USP7
  source: hgnc_symbol
  hgnc_symbol: USP7
  entrez: '7874'
- word: MDM2
  symbol: MDM2
  source: hgnc_symbol
  hgnc_symbol: MDM2
  entrez: '4193'
- word: USP7
  symbol: USP7
  source: hgnc_symbol
  hgnc_symbol: USP7
  entrez: '7874'
- word: p53
  symbol: p53
  source: hgnc_alias_symbol
  hgnc_symbol: TP53
  entrez: '7157'
- word: MDM2
  symbol: MDM2
  source: hgnc_symbol
  hgnc_symbol: MDM2
  entrez: '4193'
- word: MDMX
  symbol: MDMX
  source: hgnc_alias_symbol
  hgnc_symbol: MDM4
  entrez: '4194'
- word: MDMX
  symbol: MDMX
  source: hgnc_alias_symbol
  hgnc_symbol: MDM4
  entrez: '4194'
- word: p53
  symbol: p53
  source: hgnc_alias_symbol
  hgnc_symbol: TP53
  entrez: '7157'
- word: MDM2
  symbol: MDM2
  source: hgnc_symbol
  hgnc_symbol: MDM2
  entrez: '4193'
chemicals:
- word: Spongiacidin C
  source: MESH
  identifier: C585543
- word: Thiazole
  source: MESH
  identifier: D013844
- word: GNE-6776
  source: MESH
  identifier: C582059
- word: XL188
  source: MESH
  identifier: C490816
- word: CDDO-Me,
  source: MESH
  identifier: C445068
- word: Berberine
  source: MESH
  identifier: D001599
diseases:
- word: DM
  source: MESH
  identifier: D009223
figid_alias: PMC7142254__F3
redirect_from: /figures/PMC7142254__F3
figtype: Figure
---
